Loading
Electroacupuncture at Bilateral ST36 / Systemic Inflammatory Response Syndrome (SIRS) / Postoperative Complications (cardiopulmonary) · Interventional Study
ClinicalTrials.gov · September 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned randomized controlled trial comparing electroacupuncture at ST36 with sham acupuncture (needle without electrical stimulation) in adults undergoing cardiac surgery with cardiopulmonary bypass. The study aims to evaluate whether ST36 electroacupuncture reduces postoperative inflammation and organ dysfunction, as measured by C-reactive protein and SOFA score on postoperative day 2. No results are yet available; this record describes the protocol only.
Interventional, Randomized, Parallel, Triple masking, Treatment purpose. Systemic Inflammatory Response Syndrome (SIRS), Cardiac Surgical Procedures, Postoperative Complications (Cardiopulmonary); age from 18 Years. Intervention: Electroacupuncture Group. Compared with: Acupuncture Without Electrical Stimulation Group — Sham Comparator. n = 140. Sir Run Run Shaw Hospital (location not specified in registry record).
This is a planned randomized controlled trial comparing electroacupuncture at ST36 with sham acupuncture (needle without electrical stimulation) in adults undergoing cardiac surgery with cardiopulmonary bypass. The study aims to evaluate whether ST36 electroacupuncture reduces postoperative inflammation and organ dysfunction, as measured by C-reactive protein and SOFA score on postoperative day 2. No results are yet available; this record describes the protocol only.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
If efficacy is demonstrated, ST36 electroacupuncture could represent a non-pharmacological strategy to reduce postoperative systemic inflammation and organ dysfunction after cardiac surgery. However, results must first be reported and independently confirmed.
This is a clinical trial registry record with no reported results; the study is not yet recruiting. It describes a planned interventional design addressing an important clinical question but carries no efficacy data.
As stated by the source record.
Quoted from the source exactly as published.
If efficacy is demonstrated, ST36 electroacupuncture could represent a non-pharmacological strategy to reduce postoperative systemic inflammation and organ dysfunction after cardiac surgery. However, results must first be reported and independently confirmed.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07795112). This is a study registration, not published results. Lead sponsor: Sir Run Run Shaw Hospital. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 140 participants (ESTIMATED). Conditions: Systemic Inflammatory Response Syndrome (SIRS), Cardiac Surgical Procedures, Postoperative Complications (Cardiopulmonary). Interventions: OTHER: Electroacupuncture at Bilateral ST36; OTHER: Acupuncture Without Electrical Stimulation at Bilateral ST36. Primary outcome measures: C-Reactive Protein Level on Postoperative Day 2 , Postoperative day 2; Sequential Organ Failure Assessment Score on Postoperative Day 2 , Postoperative day 2. Brief summary: Cardiac surgery using cardiopulmonary bypass can trigger a marked systemic inflammatory response and may contribute to postoperative organ dysfunction and delayed recovery. Electroacupuncture at the Zusanli acupoint (ST36) may regulate inflammatory responses, but its clinical effects in patients undergoing cardiac surgery remain uncertain. This prospective, randomized, parallel-group study will enroll 140 adults undergoing elective cardiac surgery with cardiopulmonary bypass. After surgery and admission to the intensive care unit, participants will be randomly assigned in a 1:1 ratio to receive either bilateral ST36 electroacupuncture or a control procedure involving the same acupoint localization, skin disinfection, needle insertion, and needle retention without electrical stimulation. Both groups will receive standard postoperative care. The intervention will be administered twice for 30 minutes per session. The primary outcomes are C-reactive protein levels and Sequential Organ Failure Assessment scores on postoperative day 2. Secondary outcomes include the duration of vasoactive drug use, incidence and severity of systemic inflammatory response syndrome, duration of mechanical ventilation, length of intensive care unit and hospital stay, and perioperative inflammatory markers. The study will evaluate whether ST36 electroacupuncture can reduce postoperative inflammation and organ injury and improve recovery after cardiac surgery.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.